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ABSTRACT: The peptide hormone CNP has
recently been found to positively regulate axon branching
and growth via activation of cGMP signaling in embry-
onic dorsal root ganglion (DRG) neurons, but the cellular
mechanisms mediating the regulation of these develop-
mental processes have not been established. In this study,
we provide evidence linking CNP/cGMP signaling to
microtubule dynamics via the microtubule regulator
CRMP2. First, phosphorylation of CRMP2 can be sup-
pressed by cGMP activation in embryonic DRG neurons,
and non-phosphorylated CRMP2 promotes axon branch-
ing and growth. In addition, real time analysis of growing
microtubule ends indicates a similar correlation of
CRMP2 phosphorylation and its activity in promoting
microtubule polymerization rates and durations in both
COS cells and DRG neuron growth cones. Moreover,
direct activation of cGMP signaling leads to increased as-
sembly of dynamic microtubules in DRG growth cones.
Finally, low doses of a microtubule depolymerization
drug nocodazole block CNP/cGMP-dependent axon
branching and growth. Taken together, our results sup-
port a critical role of microtubule dynamics in mediating
CNP/cGMP regulation of axonal development. VC 2013
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INTRODUCTION
Natriuretic peptides are a family of hormones best
known for regulating renal sodium and water secre-
tion by binding to receptor guanylyl cyclases and
stimulating production of cyclic guanosine mono-
phosphate (cGMP) (Potter et al., 2006). Interestingly,
the C-type natriuretic peptide (CNP) was recently
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found to be required for central afferent bifurcation
of dorsal root ganglion (DRG) sensory neurons in the
mouse spinal cord (Schmidt et al., 2009; Zhao and
Ma, 2009). This novel function depends on the CNP
receptor Npr2 and its downstream target, cGMP-de-
pendent protein kinase 1 (PrkG1) (Schmidt et al.,
2007; Zhao et al., 2009). In embryonic DRG neuronal
culture, activation of CNP/cGMP signaling stimu-
lates axon branching, promotes axon growth, and
elicits growth cone turning (Zhao and Ma, 2009;
Zhao et al., 2009). Although CNP represents a new
class of extracellular factors regulating axonal devel-
opment, the cellular mechanisms mediating these
diverse functions are not known.
Our recent study of DRG axon branching (Zhao
et al., 2009) hints that glycogen synthase kinase 3
(GSK3) and its downstream signaling targets may be
involved in CNP functions, as GSK-3 can be directly
phosphorylated by PrkG1 and perturbation of GSK3
phosphorylation interferes with cGMP-dependent
axon branching. GSK3 is also known to regulate neu-
rogenesis, neuronal polarization and axon growth,
which all depend on the regulation of microtubule as-
sembly (Hur and Zhou, 2010). Moreover, several
microtubule regulators, including collapsin response
mediator protein-2 (CRMP2), microtubule associated
protein 1B (MAP1B) and adenomatosis polyposis coli
protein (APC) are implicated in mediating these func-
tions of GSK3 (Fukata et al., 2002; Zhou et al., 2004;
Yoshimura et al., 2005; Kim et al., 2006).
Microtubules are normally bundled in axons but
splayed apart in growth cones where they rapidly po-
lymerize and depolymerize in a fashion known as
dynamic instability (Lowery and Van Vactor, 2009).
This intrinsic property allows dynamic microtubules
to explore the intracellular space and is thought to
contribute to axon growth and guidance (Mitchison
and Kirschner, 1988; Dent and Gertler, 2003; Dent
et al., 2011) as well as collateral formation (Gallo,
2011). In fact, inhibition of microtubule dynamics
increases growth cone wandering, reduces persistent
forward movement, and blocks growth cone turning
(Tanaka et al., 1995; Challacombe et al., 1997; Buck
and Zheng, 2002; Suter et al., 2004), whereas local
stabilization or destabilization of microtubule assem-
bly promotes growth cone attraction or repulsion
(Buck and Zheng, 2002). Furthermore, dynamic
microtubules are found in nascent branching sites
(Dent and Kalil, 2001), and perturbation of their dy-
namics often interferes with branch formation, albeit
with different effects (Letourneau et al., 1986; Baas
and Ahmad, 1993; Gallo and Letourneau, 1999; Dent
et al., 2004).
Therefore, one of the cellular responses elicited by
CNP/cGMP signaling that lead to morphological
remodeling in axons could be the modulation of
microtubule dynamics. To test this hypothesis, we first
investigated phosphorylation of the GSK3 target
CRMP2 in DRG neurons. We next used real time
imaging to examine microtubule dynamics in COS
cells and growth cones of DRG neurons expressing dif-
ferent forms of CRMP2. We further analyzed microtu-
bule response in growth cones challenged by CNP/
cGMP activation. Finally, we determined whether
CNP/cGMP-dependent DRG axon branching and
growth could be blocked by a microtubule inhibitor.
Collectively, our results establish a strong connection
between microtubule regulation and the novel function
of CNP/cGMP signaling in axonal development.
METHODS
Chemicals, Animals, and DNA
Constructs
Nocodazole and 8-Br-cGMP were obtained from Sigma
(St. Louis, MO). All animal work was done according to
protocols approved by the Institutional Animal Care and
Use Committees of the University of Southern California
following the National Institutes of Health guidelines. Rat
embryos were collected from pregnant Sprague Dawley
females (purchased from Charles River Laboratories, San
Diego, CA) with the plug date designated as embryonic day
0 (E0). The short form of CRMP2 full-length cDNA
(Yuasa-Kawada et al., 2003) was cloned by PCR from
mouse brain cDNA and then subcloned into a pCAGGS-
FLAG expression vector by restriction enzyme digestions.
Single amino acid substitution mutants (T514A, T514D)
were generated by PCR-based site-directed mutagenesis,
and deletion mutants were generated by PCR. All con-
structs were verified by DNA sequencing as well as by
Western blot of proteins expressed in COS cells.
Analysis of CRMP2 Phosphorylation in
Neurons by Western Blots
Dissociated DRG neurons (4 3 105 cells/well of six-well
plate) were cultured overnight, starved for 3 hr without
NGF and stimulated for different times with 50 mM 8-Br-
cGMP. Cell lysates were prepared using ice-cold RIPA
buffer with protease inhibitors and phosphatase inhibitors.
Proteins in the lysate were then separated by SDS-PAGE
and transferred onto nitrocellulose membranes, which were
probed with the following antibodies: phospho-CRMP2
(Cole et al., 2004, 2006) and mouse anti-tubulin (DM1a).
Alexa680- (Invitrogen) and IRDye800-labeled secondary
antibodies were used for detection on an infrared imaging
system (Odyssey, LI-COR). The quantification was aver-
aged from six individual experiments and compared by the
Mann-Whitney test.
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In Vitro Branching Assay Using
Dissociated DRG Neurons
Dissociated DRG neurons were cultured as previously
described (Zhao et al., 2009). Briefly, E14 rat DRG neurons
were dissociated and cultured at 8000 cells in 20 mL collagen
gels per well and in F12 medium supplemented with N3 and
NGF (25 ng/mL). After 24 hr in culture, neurons were
treated with CNP (100 nM) or 8-Br-cGMP (50 mM). Cells
were cultured for additional 24 hr and then fixed for immu-
nostaining with a monoclonal antibody against neurofilament
(RMO270, 1:1000, gift from Dr. Virginia Lee, University of
Pennsylvania, Philadelphia, PA) and an HRP-conjugated
secondary antibody for DAB reaction (Jackson Immunologi-
cal, ME). In some experiments, nocodazole was added at the
same time as CNP and Br-cGMP treatment.
To express various constructs of CRMP2, 1 3 106 dis-
sociated DRG cells were electroporated with 2 to 3 mg of
plasmid DNA in the Amaxa nucleofector using the reagent
and program for rat DRG neurons (Lonza, Germany). After
electroporation, cells were diluted with 400 mL of growth
medium, incubated at 37C for 10 min, and then plated to-
gether with EGFP-transfected cells (1:1 or 1:2 ratio) at 3–5
3 104 cells per 20 mL collagen gels. Cells were cultured for
48 hrs and then fixed for immunostaining using a monoclo-
nal antibody against the FLAG tag (M2, 1:10,000, Sigma).
For quantification, processes extending longer than 20
mm were counted as branches. Total branch numbers were
divided by total neuron numbers to obtain average branch-
ing points. At least 50 neurons were randomly chosen for
measurement in each condition, and each experiment was
repeated at least three times. Statistical significance was
first determined by one-way ANOVA and then followed by
pair-wise Tukey’s comparison between the individual ex-
perimental condition and the control.
DRG Explant Outgrowth Assay
DRGs were cut into small pieces, plated in collagen gels, and
cultured in the presence of NGF (25 ng/mL). CNP and differ-
ent doses of nocodazole were added to the culture 24 hrs later
when the medium was replaced by fresh medium without
NGF. DRGs were fixed after another 22 hrs and stained with
neurofilament antibodies and Cy3-conjuncted secondary anti-
bodies. Axonal outgrowth (g) between the edge of the explant
and the perimeter of the halo was measured at every 45. To
normalize the size variation of explants, an outgrowth index
was calculated based on the ratio of outgrowth (g) over the ra-
dius (r) of the explant. At least four to six explants were ana-
lyzed for each condition. Statistical significance between the
control (no nocodazole6CNP) and other conditions were
determined by one-way ANOVA.
Real-Time Analysis of Microtubule
Dynamics in Live Cells
To image microtubule ends in neurons, E14 rat DRG
explants were electroporated by five 50 ms, 110V square
wave pulses using a BTX electroporator with plasmid DNA
expressing EB3-GFP (Stepanova et al., 2003). DRG
explants were then placed on poly-D-lysine and laminin
coated glass coverslips and cultured in the F12/N3 medium
with NGF overnight. On the second day, cells on the cover-
slips were moved to a pre-warmed custom-made stage
chamber (32C) on an Axiovert 200 microscope (Zeiss)
and the medium was replaced with fresh F12/N3 supple-
mented with 10 mM HEPES (pH 7.4). The GFP fluores-
cence was excited by a 100-W mercury lamp attenuated
with a neural density filter and 100-ms exposure images
were taken using a 633 apochromatic objective
(N.A.5 1.4) coupled with a 2.53 optovar and a cooled
EMCCD camera (Cascade II, Photometrics) controlled by
the Metamorph software (Molecular Devices). To follow
microtubules after Br-cGMP or CNP treatment, sequential
images at 5 to 10 s intervals were taken for a period of 2 to
4 min at specific time points (every 15 min) after the addi-
tion of 50 mM cGMP or 100 nM CNP.
To analyze microtubule dynamics in response to
CRMP2 overexpression, DRG neurons or COS cells were
electroporated or transfected with a bicistronic vector
expressing various forms of CRMP2 and EB3-GFP. Fluo-
rescence images were taken 20 hrs later at 5 or 10 s inter-
vals for 2 to 4 min using the same setup described above.
To normalize the expression level and the potential changes
caused by EB3 expression, we chose cells with similar
sized EB3 comets for analysis. To analyze microtubule as-
sembly in response to nocodazole, images were taken 5
min before and then at specific time points after nocodazole
addition.
To obtain the rate of microtubule polymerization, EB3
comets were analyzed by the recently developed dCCD
method (Garrison et al., 2012) or the plusTipTracker pro-
gram (Applegate et al., 2011). Polymerization rates were
averaged from multiple frames at a single time point for
each cell and then presented as mean6SE of multiple cells
analyzed. To obtain the durations, newly-appearing EB3
comets were manually followed frame by frame until they
disappeared, and the time intervals were measured between
the first and the last frame. EB3-GFP labeled tip length was
calculated from the growing ends identified in the dCCD
images (Garrison et al., 2012). Most data are normally dis-
tributed and the statistical significance was determined by
one-way ANOVA followed by Tukey’s multiple compari-
son. For data without normal distribution, the Mann-Whit-
ney test was used.
RESULTS
Phosphorylation of CRMP2 can be
Suppressed by cGMPActivation in DRG
Neurons
To identify potential cellular mechanisms mediating
CNP regulation of axonal development, we first stud-
ied CRMP2, a protein that influences microtubule
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assembly (Fukata et al., 2002; Yoshimura et al.,
2005) and which can be phosphorylated by GSK3
(Cole et al., 2004, 2006; Yoshimura et al., 2005). We
asked whether Br-cGMP could modulate CRMP2
phosphorylation at two GSK3 sites (T509/T514) in
cultured DRG neurons (Cole et al., 2004, 2006), as
these sites have been implicated in axon elongation
and neuronal polarity (Cole et al., 2004; Yoshimura
et al., 2005). As shown by Western blotting using a
T509/T514-specific phospho-antibody [Fig. 1(A)],
the phosphorylation level of CRMP2 at these two
sites started to decrease after treating the cells with
Br-cGMP for 15 min and reached 25% reduction
after 1 hr exposure [Fig. 1(B)]. A similar change was
also observed in DRG neurons treated with CNP
(data not shown). Thus, the biochemical analysis sug-
gests CRMP2 as a downstream target of CNP/cGMP
signaling in DRG neurons.
Phosphorylation-Dependent Promotion
of Axon Branching and Growth by
CRMP2
To test the role of CRMP2 and it phosphorylation in
axon branching and growth, we next overexpressed
CRMP2 in dissociated DRG neurons and examined
axonal morphology without activating CNP/cGMP
signaling. To normalize the potential variation of cul-
ture conditions, DRG neurons were electroporated
separately with DNA constructs of FLAG-tagged
CRMP2 or EGFP and then cultured together in colla-
gen gels. Two days after transfection, neurons stained
positive for wild-type (WT)-CRMP2 displayed more
branches than those expressing EGFP in the
same culture [Fig. 2(A)]. The branch distribution for
WT-CRMP2 showed a significant right-shift over
EGFP controls [Fig. 2(H)], and more than 70610%
WT-CRMP2-positive neurons had two or more
branches, as compared with 356 10% EGFP-
expressing cells. In addition, the average number of
branching points increases from 1.406 0.07 per neu-
ron for EGFP-expressing cells to 2.356 0.09 by for
WT-CRMP2-expressing cells [Fig. 2(I)].
We then tested the dependence of this branching
activity on CRMP2 phosphorylation at the T514 site.
We chose to focus on this site because it is critical to
mediating GSK3-depenent neuronal polarity and
tubulin binding (Yoshimura et al., 2005). Two phos-
pho-mutants were overexpressed in DRG neurons
[Fig. 2(B–G)]. One is the T514A mutant (T514-
CRMP2) that mimics the unphosphorylated active
state by blocking its phosphorylation with a substitu-
tion of threonine by alanine; and the other is T514D,
which mimics the phosphorylated form that is unable
to interact with tubulin heterodimers (Fukata et al.,
2002). As shown in Figure 2(H), the overall branch
distribution significantly shifted to the right in
T514A-CRMP2 overexpressed neurons, while the
distribution for T514D-CRMP2 cells shifted only
slightly. As a result, 846 13% T514A-CRMP2-
expressing neurons had two or more branches, while
only 386 17% EGFP-expressing neurons and
546 9% T514D-positive cells did. The average num-
ber of branching points in T514A-CRMP2 neurons
increased significantly (2.13) to 2.936 0.14 per
neuron from that of the control neurons. In contrast,
T514D-CRMP2-positive cells had 1.3x more
branches (1.836 0.10 per cells) than the control cells
[Fig. 2(I)], likely due to incomplete inhibition of
CRMP2 activity by the mutant that retains an intact
T509 site. Nonetheless, these results indicate that the
branching activity depends on the phosphorylation
state of CRMP2.
We also measured axon growth in dissociated
DRG neurons overexpressing CRMP2 [Fig. 2(J)].
Normally, the basal level of axonal length, defined by
the longest neurite, was 2146 12 mm. Overexpres-
sion of WT- or T514A-CRMP2 led to a small but sig-
nificant increase of axon length to 2576 13 mm and
2696 10 mm, respectively. However, overexpression
Figure 1 Phosphorylation of CRMP2 at T509/T514 is regu-
lated by cGMP signaling. A) Dissociated E14 rat DRG were
starved for 3 hrs and then stimulated with 50 mM Br-cGMP
for the time period indicated. Phosphorylation of CRMP2 at
T509/T514 was analyzed by Western blot with a specific
phosphoantibody. As a loading control, tubulin was probed
on the same blot. B) The relative phosphorylation level is
plotted as an average of the normalized ratio (mean6 SE) of
pCRMP2/tubulin from six different cultures and shows a
small but significant reduction after 45 min as compared with
0 min (**p< 0.01, *p< 0.05, Mann-Whitney test).
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Figure 2 CRMP2 over-expression in DRG neurons enhances axonal branch formation. A) Disso-
ciated DRG neurons were transfected with wild type (WT) CRMP2-FLAG and EGFP separately,
and then mixed together and cultured in collagen gels for 48 hr. CRMP2 expression was detected
by staining with a FLAG antibody and Cy3-conjugated secondary antibodies (red) and EGFP was
detected by its own fluorescence (green). Note the increase in branches in CRMP2-expressing neu-
rons but not in EGFP cells. Scale bar: 20 mm. B–G) Representative images of dissociated DRG neu-
rons that were transfected with EGFP (B, C), T514A (D, E) or T514D (F, G) of FLAG-tagged
CRMP2 and cultured in collagen gels for 48 hr. Scale bar: 20 mm. H, I) Comparison of axon
branching by the distribution of neurons with a different number of branches (H, mean6STD) or
by the average number of branching points (I, mean6SE) measured from neurons transfected with
plasmids expressing EGFP, WT, T514A, or T514D of CRMP2-FLAG. Both WT and T514A
showed increased branch formation (***p< 0.001, **p< 0.01, ANOVA with Tukey’s compari-
son). J) Comparison of axonal length (defined as the longest neurites, mean6 SE) of dissociated
DRG neurons transfected with different plasmids (***p< 0.001, *p< 0.05, ANOVA).
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of the T514D mutant resulted in a slight reduction of
axonal length to 1996 10 mm, which is not statisti-
cally different from that of the control neurons. These
results are consistent with the previous findings
obtained from cultured hippocampal neurons (Fukata
et al., 2002) and thus suggest CRMP2 as a likely cel-
lular mediator for CNP/cGMP signaling in DRG
axon growth and branching.
Phosphorylation-Dependent Regulation
of Microtubule Polymerization by CRMP2
in COS Cells and DRG Growth Cones
As CRMP2 is known to promote microtubule assem-
bly in cells (Fukata et al., 2002), we hypothesize that
it mediates CNP-dependent axon growth and branch-
ing by modulating microtubule dynamics. However,
the exact site of microtubule regulation is not known,
as none of the dynamic parameters has been meas-
ured in the presence of activated CRMP2. Thus, we
made a bicistronic construct that co-expressed differ-
ent forms of CRMP2 along with EB3-GFP. As EB3-
GFP binds preferentially to the growing plus-end of
microtubules (Stepanova et al., 2003), we could use a
recently developed dual color-coded display (dCCD)
method (Garrison et al., 2012) to rapidly measure
microtubule polymerization rates in the entire cell
[Fig. 3(A,B)].
We first measured polymerization rates in COS
cells cultured at 32C and compared the rates
Figure 3 Over-expression of CRMP2 promotes microtubule polymerization rates in COS cells and
DRG neuron growth cones. A–D) Microtubule assembly was analyzed by following EB3-GFP la-
beled plus-ends in COS cells (A) or DRG growth cones (C). Labeled ends were color coded and then
analyzed by the dCCD method (B and D). Scale bars: 5 mm. E–G) Comparison of microtubule poly-
merization rates (mean6SE) in COS cells (E, F) or in DRG growth cones (G) expressing EB3-GFP
alone or with different forms of CRMP2 from a bicistronic vector. Polymerization rates were calcu-
lated from single growing microtubule ends using the dCCD method (E, G) or by the plusTipTracker
program (F). In both COS cells and DRG growth cones, significant increases (p values from ANOVA
are 0.0028 (E), 0.0004 (F), and <0.0001 (G)) were found in cells expressing T514A of CRMP2 when
compared with the control cells expressing EB3-GFP alone or with T514D-CRMP2 based on Tukey’s
multiple comparisons (**p< 0.01, ***p< 0.001). Note that WT-CRMP2 also caused significant
increase in microtubule polymerization rates as compared with the EB3-GFP control in growth
cones.
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between cells expressing WT, T514A, or T514D-
CRMP2 as well as those expressing EB3-GFP alone.
The rates calculated during a 2-min period [Fig.
3(E)] increased from 2.936 0.10 mm/min in the
control cells to 3.386 0.06 mm/min in cells exp-
ressing T514A proteins. Interestingly, neither the
phosphorylated mutant (T514D) nor the WT-CRMP2
elicited any significant change (Table 1), indicating
that microtubule regulation depends on the state of
CRMP2 phosphorylation. To confirm the observation
based on the analysis by the dCCD method, we used
an automated tracking program plusTipTracker
(Matov et al., 2010) to measure the rates from the
same set of images (Table 1). Again, we found simi-
lar correlation of polymerization rates and phospho-
mutants of CRMP2 as the rates differ significantly
between T514A-expressing cells and control or
T514D-expressing cells [Fig. 3(F)].
To test whether the rate-promoting activity found
in COS cells also applies to neurons, we used the
same experimental strategy and the dCCD method to
measure microtubule polymerization rates from
dynamic microtubules in the growth cone of DRG
neurons. In neurons expressing EB3-GFP alone, the
rate was 2.966 0.13 mm/min (Table 1). However,
T514A-CRMP2 caused significant increase of the
rates by 39% to 4.126 0.14 mm/min, while the phos-
phorylation-mimicking mutant (T514D) had less
effect (3.346 0.15 mm/min, 13% increase) [Fig.
3(L), Table 1). More importantly, the rate difference
between T514A- and T415D-neurons is consistent
with that found in COS cells and demonstrates an im-
portant role for non-phosphorylated CRMP2 in pro-
moting microtubule dynamics. Interestingly, we also
found that overexpression of WT-CRMP led to a sig-
nificant increase of the rate in growth cones [28%,
Fig. 3(L), Table 1], indicating different responses
between DRG neurons and COS cells.
We also measured the durations of microtubule po-
lymerization by following the appearance and the dis-
appearance of EB3-GFP labeled ends in COS cells
and DRG growth cones. Like the rates, we found a
similar change in COS cells measured over a period
of 4 min [Fig. 4(A)], increasing from 49.946 2.84 s
in the control cells to 72.826 5.15 s in cells express-
ing T514A, but not in T514D-cells (49.576 2.57 s)
(Table 2). A similar increase was also found in DRG
neuron growth cones. Twenty hours after transfec-
tion, T514A-CRMP2 increased the durations by 36%
to 99.226 5.48 s from 65.226 3.38 s in the control
growth cones [Fig. 4(B), Table 2]. In both cases,
WT-CRMP2 also led to significant duration increase
by 30% to 66.106 4.71 s and 86.906 4.60 s
respectively.
Thus, these results reveal an important function of
CRMP2 phosphorylation in regulating microtubule
dynamics in intact cells and demonstrate a nice corre-
lation with its activity in axon branching and growth
(Fig. 2).
CNP/cGMPActivation Modulates
Microtubule Assembly Dynamics in DRG
Neuron Growth Cones
To test whether microtubule assembly is indeed a tar-
get of CNP/cGMP signaling, we next examined EB3-
GFP-comets in DRG neuron growth cones challenged
by Br-cGMP or CNP [Fig. 5(A,B)]. We first meas-
ured the polymerization rates using the dCCD
method and compared the data pooled from several
experiments. We calculated the ratio of the rates
measured after stimulation over the initial rates (at 0
min) in the same growth cone and compared the ratio
between control and CNP/cGMP-activated growth
cones [Fig. 5(C)]. A modest but significant increase
(8%, p5 0.008, t-test, n5 11) was found 15 min after
the addition of Br-cGMP or CNP to the culture me-
dium, at a time when CRMP2 phosphorylation starts
to decrease (Fig. 1). This increase persisted for at
least 30 min when the rates were analyzed at 30 min
and 45 min after activation [Fig. 5(C)]. However, it
was not observed in control growth cones, indicating
that the increase observed above is specific for CNP/
cGMP activation. In addition, the same rate increase
was observed when the rates were analyzed by track-
ing EB3-GFP labels manually (data not shown).
Table 1 Summary of the Rates (Mean6SE) of Microtubule Polymerization (mm/min) in COS Cells and Growth
Cones of DRG Neurons Expressing Different Forms of CRMP2
COS Cells
DRG Growth Cones
dCCD plusTipTracker dCCD
Control 2.936 0.10 (7) 2.866 0.10 (7) 2.966 0.13 (8)
CRMP2-WT 3.096 0.12 (7) 3.196 0.07 (7) 3.806 0.16 (8)
CRMP2-T514A 3.386 0.06 (10) 3.496 0.09 (10) 4.126 0.14 (8)
CRMP2-T514D 2.976 0.07 (10) 3.016 0.10 (10) 3.346 0.15 (8)
Numbers in the parentheses indicate the number of cells or growth cones analyzed for each condition.
Regulating Microtubule Dynamics by CNP Signaling 679
Developmental Neurobiology
Next, we measured polymerization durations in the
growth cones challenged by Br-cGMP and found
they were increased by nearly 30% [Fig. 5(D]. The
increase started at 15 min and persisted for the next
30 min. Taken together, microtubule assembly in
DRG neurons is greatly enhanced after cGMP activa-
tion as a result of increased microtubule dynamics,
which is consistent with the data obtained for
CRMP2 above (Figs. 3 and 4).
Low Doses of Nocodazole Inhibit CNP/
cGMP-Dependent Axon Branching in
DRG Neurons
To test whether increased polymerization rates from
dynamic microtubules is required for CNP/cGMP-de-
pendent axonal development, we examined the effect
of a microtubule depolymerizing drug nocodazole on
DRG axon branching in culture, as low doses of
nocodazole have been used to block dynamics but
not overall microtubule assembly (Tanaka et al.,
1995; Rochlin et al., 1996; Gallo and Letourneau,
1999; Dent et al., 2004).
To first confirm the inhibition of microtubule dy-
namics, we used the dCCD method to analyze EB3-
GFP labeled microtubule ends in COS cells [Fig.
6(A–D)]. We found that microtubules remained
dynamic after the treatment with low doses of noco-
dazole, but the polymerization rates decreased within
10 min and persisted at the reduced rates for at least
30 min. The reduction was 186 4% at 33 nM noco-
dazole, but became more profound and reached
356 6% at 100 nM nocodazole [Fig. 6(E)]. The
rate reduction appears to correlate well with that of
the EB3-GFP labeled tip length, which exhibited sim-
ilar time- and dose-dependent reduction [Fig. 6(F)].
Thus, consistent with previous studies (Vasquez
et al., 1997; Jaworski et al., 2009), low doses of noco-
dazole can be used to perturb microtubule dynamics
without disassembling microtubule networks.
Following the dose analysis in COS cells, we next
tested the effect of nocodazole on DRG neurons at
concentrations between 0 and 100 nM. These neurons
normally displayed simple morphology after two
days of culture in collagen gels, with 286 7%
(mean6 STD) of neurons having no branches,
366 7% having one branch, 21v5% having two, and
less than 15% having three or more branches [Fig.
7(A,I)]. As previously reported (Zhao and Ma, 2009),
including CNP in the culture in the last 24 hr resulted
Table 2 Summary of the Durations (Mean6 SE) of
Microtubule Polymerization in COS Cells or DRG Neu-
rons Expressing Different Forms of CRMP2
COS Cells DRG Growth cones
Control 49.946 2.84 (25) 65.226 3.38 (31)
CRMP2-WT 66.106 4.71 (31) 86.906 4.60 (29)
CRMP2-T514A 72.826 5.15 (23) 99.226 5.48 (29)
CRMP2-T514D 49.576 2.57 (23) 57.716 2.88 (24)
Numbers in the parentheses indicate the number of cells, growth
cones, or axons analyzed for each condition.
Figure 4 Overexpression of CRMP2 promotes microtubule polymerization durations in COS cells
and DRG neuron growth cones. Comparison of microtubule polymerization durations (mean6 SE)
in COS cells (A) or in DRG growth cones (B) expressing EB3-GFP alone or with different forms of
CRMP2 from a bicistronic vector. Significant differences (ANOVA) are found in cells expressing
WT or T514A of CRMP2 when compared with control cells expressing EB3-EGFP alone or
CRMP2-T514D based on Tukey’s multiple comparisons (*p< 0.05, **p< 0.01, ***p< 0.001).
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in >71% of neurons developing more than two
branches [Fig. 7(E)]. As a consequence, the average
branching number per cell is increased from
1.306 0.09 to 2.326 0.04 [mean6SE, Fig. 7(K)].
However, the addition of nocodazole simultaneously
with CNP treatment reduced this increase and
returned it to the control level in a concentration-de-
pendent manner. With increasing nocodazole concen-
trations, the distribution of neurons with different
number of branches shifts toward the left [Fig. 7(J)],
indicating a negative effect on branching. At 10 nM
nocodazole, 696 16% (mean6 STD) of CNP-treated
neurons had more than two branches, while at 33 nM
and 100 nM, the percentage was lowered to
466 18% and 146 15%, respectively [Fig. 7(F–
H,J)]. The change in distribution can be also
demonstrated by the decrease in the average branch-
ing point, which was lowered to 1.946 0.09,
1.206 0.05 and 0.706 0.04 per neuron at these three
concentrations respectively. As a comparison, noco-
dazole also reduced the basal level of branching [Fig.
7(B–D,K)]: in the presence of 10 nM nocodazole, the
average branching point was 1.106 0.08 per cell,
while at 33 nM and 100 nM, it declined to
0.766 0.02 and 0.396 0.07 per cell, respectively.
We also tested the nocodazole effect on Br-cGMP-
treated DRG neurons and obtained similar results, as
nocodazole at 10 to 100 nM inhibited axon branching
of Br-cGMP-treated neurons [Fig. 7(L)]. Further-
more, to exclude the secondary effect of nocodazole
on axon growth, we normalized the branching num-
ber to the length of the main axons. Again, we found
Figure 5 CNP or cGMP activation promotes microtubule assembly in DRG neuron growth cones.
A, B) Microtubule assembly was analyzed in the growth cones of EB3-GFP-expressing DRG neu-
rons that were treated without (A) or with 50 mM Br-cGMP (B). Scale bar: 5 mm. C) Microtubule
polymerization rates in growth cones were calculated by the dCCD method and plotted as the ratios
between those at time 15’, 30, or 45’ after stimulation and those at time 0’. The rate ratios are close
to one in control growth cones (n> 5), but increased significantly in growth cones (n> 7) treated
with 50 mM Br-cGMP or 100 nM CNP (*p< 0.05, **p< 0.001, Mann-Whitney test). D) Durations
of microtubule polymerization in growth cones were calculated and plotted as the ratio between
those at time 15’, 30, or 45’ and those at time 0’. The duration ratios are close to one in control
growth cones (n5 10), but has >20% increase in growth cones (n5 11) treated with 50 mM Br-
cGMP (*p< 0.05, **p< 0.001, Mann-Whitney test).
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a dose-dependent reduction of both CNP and
Br-cGMP-stimulated branching [Fig. 7(M,N)], indi-
cating that this inhibition on axon branching is direct.
Thus, our pharmacological study demonstrates that
dynamic microtubules are required for CNP/cGMP-
dependent axon branching of DRG neurons.
CNP-Stimulated Axon Growth can be
Attenuated by Nocodazole
Since our previous study had shown that CNP could
stimulate axon growth in DRG explant culture (Zhao
and Ma, 2009), we tested whether this positive effect
could also be blocked by nocodazole. Consistent with
our previous study, addition of CNP to DRG explants
leads to increased axon growth, with longer and
denser axons surrounding the explant (Fig. 8). This
effect can be quantified and compared by the out-
growth index, which increased from 2.306 0.11
(mean6 SE) in the untreated explants to 3.366 0.09
in the CNP-treated explants [Fig. 8(I)]. However,
addition of nocodazole to the culture at the same time
of CNP treatment blocked this increase in a dose-de-
pendent manner. The minimum effective nocodazole
concentration was 33 nM, at which the axons at the
periphery of the explants were less dense, and the
Figure 6 Low doses of nocodazole affect microtubule dynamics in COS cells. A–H) Analysis of
microtubule assembly in EB3-GFP-expressing COS cells (A, C, E, G) challenged by nocodazole at
two low doses (33 nM or 100 nM). EB3-GFP labeled microtubule plus-ends were imaged at 0 min
(A–D) or 30 min (E–H) after nocodazole treatment, and then analyzed by the dCCD method (B, D,
E, H) to calculate polymerization rates and EB3-GFP labeled tip length. Scale bar: 5 mm. I, J) Com-
parison of microtubule polymerization rates or EB3-GFP labeled tip length in COS cells treated with
different doses of nocodazole. Both parameters were calculated and plotted as the ratio between the
values obtained at different time points after nocodazole treatment and those obtained 5 min before
treatment. For both parameters, 100 nM nocodazole led to stronger reduction as compared with
33 nM.
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outgrowth index decreased to 2.466 0.10. Interest-
ingly, the same concentration of nocodazole reduced
the basal level growth from 2.306 0.11 to
1.406 0.12. At the highest dose tested (100 nM),
nocodazole reduced the basal growth to 1.036 0.05
and the CNP-induced growth to 1.966 0.03. Thus,
these results demonstrate the importance of microtu-
bule assembly in both basal and CNP-stimulated
axon growth of DRG neurons.
DISCUSSION
CNP/cGMP signaling provides a novel mechanism
that guides axons to connect with proper targets dur-
ing development. Following the recent identification
of this pathway in regulating axon branching, growth,
and guidance (Schmidt et al., 2007, 2009; Zhao and
Ma, 2009; Zhao et al., 2009), we provide biochemi-
cal, cell biological and pharmacological data to link
this signaling pathway to downstream regulation of
microtubule polymerization (Fig. 9).
First, we show that the microtubule regulator
CRMP2 is a downstream target of CNP/cGMP sig-
naling. Our previous study has identified GSK3 as a
modulator of cGMP-dependent branching (Zhao
et al., 2009), and now we extend this finding to
CRMP2, one of the GSK3 substrates that is known to
regulate neuronal polarization, axonogenesis, axon
growth and branching (Inagaki et al., 2001; Fukata
et al., 2002; Yuasa-Kawada et al., 2003; Yoshimura
et al., 2005). Here, we show that the CRMP2 phos-
phorylation at two of the GSK3 sites is reduced by
cGMP activation in DRG neurons [Figs.1 and 9(A)].
The change follows a time course that mirrors that
Figure 7 Low doses of nocodazole block CNP/cGMP-dependent axon branching in dissociated
DRG culture. A–H) Dissociated DRG neurons were cultured in collagen gels for 24 hr and then
treated with different concentrations of nocodazole in the presence of buffer (A–D) or 100 nM CNP
(E–H). Cells are visualized by HRP staining with a neurofilament antibody. Scale bar: 100 mm. I–
N) Comparison of axon branching by the distribution of neurons (mean6STD) with different num-
bers of branches (I, J), or by the average number (mean6SE) of branching points (K, L) or branch-
ing points per 200 mm axon length (M, N) measured from neurons cultured with buffer as controls
(I), 100 nM CNP (J, K, M) or 50 mM Br-cGMP (L, N) under different nocodazole concentrations.
Significance is shown for samples that are different from the corresponding 0 nM nocodazole sam-
ples (**p< 0.005, ***p< 0.001, ANOVA with Tukey’s comparison).
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of GSK3 phosphorylation (Zhao et al., 2009). In addi-
tion, overexpression of different phosphorylation
forms of CRMP2 led to consistent effects on DRG
axon branching and growth. These results are consist-
ent with the disinhibition model in which CNP/
cGMP activation leads to GSK3 phosphorylation,
hence relieving CRMP2 from the inactive phospho-
rylated state (Kim et al., 2006; Zhao et al., 2009).
In addition, our live cell imaging study supports
the notion that regulation of microtubule dynamics
results from the activation/inactivation of this signal-
ing pathway. Using EB3-GFP to analyze microtubule
dynamics, we find that CRMP2 stimulates polymer-
ization rates and durations in both COS cells and
DRG neuron growth cones, and demonstrate its de-
pendence on phosphorylation state [Figs. 4 and
9(A)]. By comparing the measurement in response to
CNP/cGMP activation, we also demonstrate that acti-
vation of cGMP signaling leads to 8% rate increase
and 30% duration increase in growth cones (Fig. 5,
Tables 1 and 2). This increase in microtubule dynam-
ics induced by a positive cue is consistent with the
opposite change elicited by a negative extracellular
cue, Sema3A (Dent et al., 2004). Thus, our data
clearly point to the sites of microtubule dynamics
that can be regulated by CNP and demonstrate a
mechanism that is shared by other extracellular cues.
Finally, we provide pharmacological evidence
linking CNP/cGMP signaling to microtubule dynam-
ics. We show that low doses of nocodazole that inter-
fere with dynamic microtubules (Fig. 6) abolished
both CNP- and cGMP-elicited branch formation (Fig.
7) and CNP-stimulated axon growth (Fig. 8) in the
DRG neuron culture [Fig. 9(A)]. The does responses
are slightly different at the highest dose (100 nM)
tested, as CNP/cGMP-induced branching was inhib-
ited completely to the similar level as the controls
[Fig. 7(K–N)], while CNP-stimulated axon growth in
explants was not [Fig. 8(I)]. Such difference may
suggest that microtubules regulated by CNP/cGMP
signaling have different impacts on axon branching
and growth. It may also suggest that CNP activation
can counteract the inhibitory effect of nocodazole
during axon growth.
Since CNP/cGMP signaling is required for bifurca-
tion in vivo (Schmidt et al., 2007, 2009; Zhao and
Ma, 2009; Zhao et al., 2009), the branching activity
we study in culture may reflect a general collateral
mechanism as recently proposed (Gibson and Ma,
2011). Following this logic, our result is thus consist-
ent with the role of dynamic microtubules in collat-
eral branching of cortical axon stimulated by Netrin
(Dent et al., 2004). It is also consistent with another
finding of a similar reduction in axon branching by
taxol, which perturbs microtubule dynamics by stabi-
lization (Letourneau et al., 1986). However, our
result differs from two past studies, in which
Figure 8 Low doses of nocodazole block CNP-stimulated
axon growth from DRG explants. A–H) DRG explants were
cultured in collagen gels for 24 hr and then treated with differ-
ent concentrations of nocodazole in the absence (A–D) or pres-
ence (E–H) of 100 nM CNP. Cells were fixed and stained with
a neurofilament antibody and a fluorescently labeled secondary
antibody. Scale bar: 200 mm. I) Comparison of axon growth by
the outgrowth index (g/r, mean6 SE), which is calculated by
the ratio of outgrowth (g) over diameter (r) of each explant.
Significance is shown for samples that are different from the
controls with 0 nM nocodazole (***p< 0.001, ANOVA).
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inhibiting microtubule dynamics did not affect spon-
taneous branch formation in embryonic chick DRG
neurons (Gallo and Letourneau, 1999) or even
enhanced branch formation in neonatal sympathetic
neurons (Baas and Ahmad, 1993). These differences
likely result from different culture conditions, espe-
cially substrates, used in these studies. For example,
our neurons were cultured in the three-dimensional
(3D) collagen gel matrix, while the other studies
employed two-dimensional (2D) surfaces coated with
fibronectin, laminin or poly-ornithine (Letourneau
et al., 1986; Baas and Ahmad, 1993; Gallo and
Letourneau, 1999). As the cellular responses can be
very different under these conditions (Baker and
Chen, 2012), branches formed in our 3D cultures or
on 2D poly-ornithine (Letourneau et al., 1986) can be
sensitive to perturbation of microtubule dynamics,
whereas they can still form or even increase produc-
tion on more permissive 2D substrates (Baas and
Ahmad, 1993; Gallo and Letourneau, 1999), perhaps
using other mechanisms such as microtubule
translocation.
Therefore, our study provides three lines of evi-
dence that jointly support a molecular pathway in
which CNP/cGMP activation leads to microtubule as-
sembly during axon branching and growth [Fig.
9(B)]. Although our study points only to the role of
dynamic microtubules, it is likely that such regulation
also cooperates with microtubule transport and actin
dynamics to promote axon growth and branching
(Gallo, 2011). In growth cones, dynamic microtu-
bules stimulated by CNP can increase exploration of
the space created by actin-led protrusion (Dent and
Gertler, 2003; Lowery and Van Vactor, 2009; Dent
et al., 2011). Similar changes may occur during
branching, when activated CNP/cGMP signaling can
increase local microtubule assembly either away
from the main growth cone or at a new site along the
axon. The resulting microtubule assembly can then
help initiate a new growth cone by either increasing
local actin dynamics or by stabilizing actin rich pro-
trusion (Schaefer et al., 2008). In addition, increased
microtubules assembled locally may allow severing
proteins to generate more short microtubules to be
transported to the nascent branch thereby promoting
branch maturation, a mechanism that is well sup-
ported by EM and imaging studies (Yu et al., 1994;
Qiang et al., 2010). Thus, dynamic microtubules do
not work alone to achieve morphological remodeling
needed for axonal development, but can be a key tar-
get in branching and growth stimulated by extracellu-
lar factors (Kim et al., 2006; Purro et al., 2008).
In conclusion, our current study demonstrates
microtubule polymerization as a potential target
for CNP/cGMP signaling in regulating axonal devel-
opment. Our results provide the foundation for
Figure 9 Regulation of microtubule assembly in promoting axon branching and growth by CNP
signaling. A) Summary of the hypothesis and the three lines of evidence that support it. Here, acti-
vated CNP/cGMP signaling leads to decreased phosphorylation of CRMP2 (p-CRMP2), which acti-
vates microtubule assembly and axon branching/growth. The supporting evidence is based on
correlative observations from biochemical, cell biological, and pharmacological studies. NOC:
nocodazole. B) The proposed molecular pathway connecting the extracellular cue CNP to dynamic
microtubule polymerization. Here, CNP binds to its cell surface receptor Npr2, which catalyzes the
production of cGMP. cGMP-activated PrkG1 can phosphorylate GSK3 (p-GSK3) and prevent it
from phosphorylating CRMP2. Following that in A), decreased CRMP2 phosphorylation
(p-CRMP2) then leads to stimulation of microtubule polymerization that is needed for axon branch-
ing and growth.
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further understanding the cell biological mechanisms
of axon branching, growth, and guidance. As a recent
study has suggested a role of microtubule stabiliza-
tion in nerve regeneration (Hellal et al., 2011), our
study of microtubule responses to a positive extracel-
lular cue also supports the idea of targeting microtu-
bule assembly to neutralize environmental inhibition
of nerve growth in the mammalian central nervous
system.
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